ERYTHROID DIFFERENTIATION AND POLY (ADP-RIBOSE) SYNTHESIS IN FRIEND LEUKEMIA CELLS
Nicotinamide, a specific inhibitor of poly (ADP-ribose) synthetase, was found to be a moderate inducer of hemoglobin synthesis in Friend erythroid leukemia cells (FLC). Therefore, the effect of other inducers, such as dimethyl sulfoxide (DMSO), hexamethylene-bisacetamide (HMBA), and butyrate, on pol...
Saved in:
| Published in | GANN Japanese Journal of Cancer Research Vol. 70; no. 1; pp. 37 - 46 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Japan
The Japanese Cancer Association
01.01.1979
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0016-450X |
| DOI | 10.20772/cancersci1959.70.1_37 |
Cover
| Summary: | Nicotinamide, a specific inhibitor of poly (ADP-ribose) synthetase, was found to be a moderate inducer of hemoglobin synthesis in Friend erythroid leukemia cells (FLC). Therefore, the effect of other inducers, such as dimethyl sulfoxide (DMSO), hexamethylene-bisacetamide (HMBA), and butyrate, on poly (ADP-ribose) synthesis was examined. The extent of poly (ADP-ribose) synthesis in nuclei of FLC treated with DMSO or HMBA began to decrease before many phenotypic changes including hemoglobin production and reached 30∼50% of the level of nontreated control when the cells enter the stationary phase. FLC variants unresponsive to HMBA or DMSO did not exhibit as low an activity of poly (ADP-ribose) synthesis as their parent cells did by treatment with these inducers. In contrast, butyrate stimulated poly (ADP-ribose) synthesis transiently but distinctly (about 50%) at an early stage of culture (6∼24hr), but suppressed it at a later stage. Neither the cell growth nor degradation of poly (ADP-ribose) is correlated with the effect of inducers. These results suggest that the level of poly (ADP-ribose) synthesis is correlated with the differentiation of FLC. |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ISSN: | 0016-450X |
| DOI: | 10.20772/cancersci1959.70.1_37 |